A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

被引:166
作者
Ledgerwood, J. E. [1 ]
Costner, P. [1 ]
Desai, N. [1 ]
Holman, L. [1 ]
Enama, M. E. [1 ]
Yamshchikov, G. [1 ]
Mulangu, S. [1 ]
Hu, Z. [1 ]
Andrews, C. A. [1 ]
Sheets, R. A. [1 ]
Koup, R. A. [1 ]
Roederer, M. [1 ]
Bailer, R. [1 ]
Mascola, J. R. [1 ]
Pau, M. G. [2 ]
Sullivan, N. J. [1 ]
Goudsmit, J. [2 ]
Nabel, G. J. [1 ]
Graham, B. S. [1 ]
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] Crucell Holland BV, Leiden, Netherlands
关键词
Adenovirus; Gene-based vaccines; Ebola; Filovirus vaccine; TYPE-1 GAG GENE; ADENOVIRUS VECTORS; NONHUMAN-PRIMATES; HIV-1; VACCINE; OF-CONCEPT; CANDIDATE VACCINE; HEMORRHAGIC-FEVER; INDUCED IMMUNITY; PHASE-1; SAFETY; RHESUS-MONKEYS;
D O I
10.1016/j.vaccine.2010.10.037
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ebola virus causes irregular outbreaks of severe hemorrhagic fever in equatorial Africa. Case mortality remains high; there is no effective treatment and outbreaks are sporadic and unpredictable. Studies of Ebola virus vaccine platforms in non-human primates have established that the induction of protective immunity is possible and safety and human immunogenicity has been demonstrated in a previous Phase I clinical trial of a 1st generation Ebola DNA vaccine. We now report the safety and immunogenicity of a recombinant adenovirus serotype 5 (rAd5) vaccine encoding the envelope glycoprotein (GP) from the Zaire and Sudan Ebola virus species, in a randomized, placebo-controlled, double-blinded, dose escalation, Phase I human study. Thirty-one healthy adults received vaccine at 2 x 10(9) (n = 12), or 2 x 10(10) (n = 11) viral particles or placebo (n = 8) as an intramuscular injection. Antibody responses were assessed by ELISA and neutralizing assays; and T cell responses were assessed by ELISpot and intracellular cytokine staining assays. This recombinant Ebola virus vaccine was safe and subjects developed antigen specific humoral and cellular immune responses. Published by Elsevier Ltd.
引用
收藏
页码:304 / 313
页数:10
相关论文
共 47 条
[1]   Comparison of multiple vaccine vectors in a single heterologous prime-boost trial [J].
Barefoot, Brice ;
Thornburg, Natalie J. ;
Barouch, Daniel H. ;
Yu, Jae-sung ;
Sample, Christopher ;
Johnston, Robert E. ;
Liao, Hua Xin ;
Kepler, Thomas B. ;
Haynes, Barton F. ;
Ramsburg, Elizabeth .
VACCINE, 2008, 26 (48) :6108-6118
[2]   Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine against Simian Immunodeficiency Virus Challenge in Rhesus Monkeys [J].
Barouch, Dan H. ;
Liu, Jinyan ;
Lynch, Diana M. ;
O'Brien, Kara L. ;
La Porte, Annalena ;
Simmons, Nathaniel L. ;
Riggs, Ambryice M. ;
Clark, Sarah ;
Abbink, Peter ;
Montefiori, David C. ;
Landucci, Gary ;
Forthal, Donald N. ;
Self, Steven G. ;
Carville, Angela ;
Mansfield, Keith ;
Goudsmit, Jaap .
JOURNAL OF VIROLOGY, 2009, 83 (18) :9584-9590
[3]   Adenovirus vector-based vaccines for human immunodeficiency virus type 1 [J].
Barouch, DH ;
Nabel, GJ .
HUMAN GENE THERAPY, 2005, 16 (02) :149-156
[4]   Discovery of Swine as a Host for the Reston ebolavirus [J].
Barrette, Roger W. ;
Metwally, Samia A. ;
Rowland, Jessica M. ;
Xu, Lizhe ;
Zaki, Sherif R. ;
Nichol, Stuart T. ;
Rollin, Pierre E. ;
Towner, Jonathan S. ;
Shieh, Wun-Ju ;
Batten, Brigid ;
Sealy, Tara K. ;
Carrillo, Consuelo ;
Moran, Karen E. ;
Bracht, Alexa J. ;
Mayr, Gregory A. ;
Sirios-Cruz, Magdalena ;
Catbagan, Davinio P. ;
Lautner, Elizabeth A. ;
Ksiazek, Thomas G. ;
White, William R. ;
McIntosh, Michael T. .
SCIENCE, 2009, 325 (5937) :204-206
[5]   Outbreaks of filovirus hemorrhagic fever: Time to refocus on the patient [J].
Bausch, Daniel G. ;
Feldmann, Heinz ;
Geisbert, Thomas W. ;
Bray, Mike ;
Sprecher, A. G. ;
Boumandouki, Paul ;
Rollin, Pierre E. ;
Roth, Cathy .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 :S136-S141
[6]   Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial [J].
Buchbinder, Susan P. ;
Mehrotra, Devon V. ;
Duerr, Ann ;
Fitzgerald, Daniel W. ;
Mogg, Robin ;
Li, David ;
Gilbert, Peter B. ;
Lama, Javier R. ;
Marmor, Michael ;
del Rio, Carlos ;
McElrath, M. Juliana ;
Casimiro, Danilo R. ;
Gottesdiener, Keith M. ;
Chodakewitz, Jeffrey A. ;
Corey, Lawrence ;
Robertson, Michael N. .
LANCET, 2008, 372 (9653) :1881-1893
[7]   Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge [J].
Bukreyev, Alexander ;
Marzi, Andrea ;
Feldmann, Friederike ;
Zhang, Liqun ;
Yang, Lijuan ;
Ward, Jerrold M. ;
Dorward, David W. ;
Pickles, Raymond J. ;
Murphy, Brian R. ;
Feldmann, Heinz ;
Collins, Peter L. .
VIROLOGY, 2009, 383 (02) :348-361
[8]   Successful topical respiratory tract immunization of primates against ebola virus [J].
Bukreyev, Alexander ;
Rollin, Pierre E. ;
Tate, Mallory K. ;
Yang, Lijuan ;
Zaki, Sherif R. ;
Shieh, Wun-Ju ;
Murphy, Brian R. ;
Collins, Peter L. ;
Sanchez, Anthony .
JOURNAL OF VIROLOGY, 2007, 81 (12) :6379-6388
[9]   Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene [J].
Casimiro, DR ;
Tang, AM ;
Chen, L ;
Fu, TM ;
Evans, RK ;
Davies, ME ;
Freed, DC ;
Hurni, W ;
Aste-Amezaga, JM ;
Guan, LM ;
Long, R ;
Huang, LY ;
Harris, V ;
Nawrocki, DK ;
Mach, H ;
Troutman, RD ;
Isopi, LA ;
Murthy, KK ;
Rice, K ;
Wilson, KA ;
Volkin, DB ;
Emini, EA ;
Shiver, JW .
JOURNAL OF VIROLOGY, 2003, 77 (13) :7663-7668
[10]   Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene [J].
Casimiro, DR ;
Chen, L ;
Fu, TM ;
Evans, RK ;
Caulfield, MJ ;
Davies, ME ;
Tang, A ;
Chen, MC ;
Huang, LY ;
Harris, V ;
Freed, DC ;
Wilson, KA ;
Dubey, S ;
Zhu, DM ;
Nawrocki, D ;
Mach, H ;
Troutman, R ;
Isopi, L ;
Williams, D ;
Hurni, W ;
Xu, Z ;
Smith, JG ;
Wang, S ;
Liu, X ;
Guan, LM ;
Long, R ;
Trigona, W ;
Heidecker, GJ ;
Perry, HC ;
Persaud, N ;
Toner, TJ ;
Su, Q ;
Liang, XP ;
Youil, R ;
Chastain, M ;
Bell, AJ ;
Volkin, DB ;
Emini, EA ;
Shiver, JW .
JOURNAL OF VIROLOGY, 2003, 77 (11) :6305-6313